Interactive atlas unveils immune changes in multiple myeloma
Multiple Myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health issues. The ...
Tag: Myeloma
Using advanced CRISPR to boost efficiency of CAR-T cell therapies
CAR-T cells are highly effective in treating selected blood cancers. However, challenges remain with this new therapy, which was first ...
Overcoming cancer relapse with CAR-Enhancer therapy
Even as they have revolutionized the treatment of certain forms of cancer, CAR T-cell therapies have been shadowed by a ...
Evolving treatment paradigms in multiple myeloma could improve patient outcomes
The , the second most common blood cancer, is shifting rapidly, with newly diagnosed patients increasingly being treated with a ...
Proteins in the blood could warn people of cancer more than seven years before it is diagnosed
In a recent study published in Nature Communications, researchers from the United Kingdom (UK) investigated associations between 1,463 plasma proteins ...
More walkable neighborhoods have a lower incidence of obesity-related cancers among women
In a recent study published in the journal Environmental Health Perspectives, researchers have found that women living in neighborhoods characterized ...
Breakthrough trial may improve diagnosis and life outcomes for patients with high-risk myeloma
Findings from a new medical trial, recently published in a prestigious scientific journal, may significantly improve life outcomes for patients ...
Phase III ZUMA-7 trial: Patients with high-risk large B-cell lymphoma lived longer with axi-cel
Patients with early relapsed or refractory large B-cell lymphoma had significantly improved overall survival when treated with the chimeric antigen ...
CAR T-cell therapy produces impressive results in first clinical trial in patients with multiple myeloma
A therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced ...
Houston Methodist researchers receive CPRIT funding to research two of the most lethal cancers
Two Houston Methodist cancer researchers have been awarded a half million dollars in funding from the Cancer Prevention and Research ...
